v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:      
Net loss $ (398,030) $ (181,078) $ (331,552)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Stock-based compensation, net of amounts capitalized 182,089 76,981 75,851
Non-cash interest expense 25,724 46,450 44,647
Deferred income taxes (11,306) 1 (3,224)
Depreciation and amortization 60,247 24,889 26,864
Amortization of contract acquisition costs 6,298 5,647 7,033
Provision for doubtful accounts 9,084 5,912 8,693
Loss (gain) on fair value adjustments 47,041 (12,200) 26,594
Debt issuance costs expensed related to SAFEs 2,913 0 0
Loss on extinguishment of debt 117,978 0 0
Other (900) 365 159
Changes in operating assets and liabilities, net of effect of business acquisitions:      
Accounts receivable (26,031) (24,614) (21,149)
Prepaid expenses and other current assets (17,712) (1,117) 1,784
Contract acquisition costs (23,972) (23,685) 0
Other non-current assets 20 (1,302) (6,933)
Accounts payable 3,082 17,093 (9,630)
Accrued expenses and other current liabilities 45,896 6,647 33,170
Deferred revenue 9,992 6,578 8,787
Operating lease right-of-use asset and operating lease liabilities, net (383) 2,256 173
Other non-current liabilities 1,641 771 (27,630)
Net cash provided by (used in) operating activities 33,671 (50,406) (166,363)
Cash flows from investing activities:      
Capitalized software development costs (17,990) (15,309) (16,743)
Purchases of property and equipment (917) (994) (561)
Purchases of investments (156,290) 0 0
(Increase) decrease in corporate card receivables (27,481) 65,052 (84,449)
Cash consideration for business acquisition, net of cash acquired 0 (3,879) (7,026)
Other (354) 0 0
Net cash (used in) provided by investing activities (203,032) 44,870 (108,779)
Cash flows from financing activities:      
Proceeds from stock option exercises 23,893 4,540 9,059
Proceeds from borrowings of debt 216,482 86,187 206,419
Proceeds from issuance of SAFEs 155,000 0 0
Payments of borrowings of debt (550,511) (35,758) (725)
Payments for debt issuance costs (11,151) (1,512) 0
Payments of deferred offering costs (8,795) 0 0
Payment of deferred consideration in business combinations (712) (903) (2,133)
Proceeds from issuance of common stock in IPO, net of underwriting costs 713,302 0 0
Taxes collected from selling shareholders stock option exercises 15,556 0 0
Taxes remitted for selling shareholders stock option exercises (15,527) 0 0
Payment of tax withholdings on settlement of RSUs (17,728) 0 0
Proceeds from exercise of warrants 110 0 0
Net cash provided by financing activities 519,919 52,554 212,620
Effect of exchange rate changes on cash, cash equivalents and restricted cash 6,921 (3,805) (414)
Net increase (decrease) in cash, cash equivalents and restricted cash 357,479 43,213 (62,936)
Cash, cash equivalents and restricted cash, beginning of period 310,595 267,382 330,318
Cash, cash equivalents and restricted cash, end of period 668,074 310,595 267,382
Supplemental disclosure of cash flow information:      
Cash paid for interest 25,575 29,547 18,634
Cash paid for income taxes 17,188 8,539 6,368
Noncash investing and financing activities:      
Vesting of early exercised stock options 918 1,658 312
Capitalized stock-based compensation for internal-use software development costs 4,933 2,319 1,130
Deferred offering costs not yet paid 495 0 0
Conversion of redeemable convertible preferred stock to common stock 1,301,120 0 0
Conversion of SAFEs to equity upon IPO 196,275 0 0
Reclassification of preferred stock warrants & SAFE warrants to equity upon IPO 31,343 0 0
Conversion of convertible notes to equity upon IPO $ 320,699 $ 0 $ 0